Skip to main content
. 2017 Sep 28;8(54):92401–92410. doi: 10.18632/oncotarget.21359

Figure 2.

Figure 2

Progression-free survival (A) by blinded independent review and overall survival curves (B) of 60 patients with advanced pancreatic cancer treated with nab-paclitaxel plus S-1.